Testosterone gel vs. injections: what TRT comparisons get wrong

What did @relatosaimicro actually say?

Honestly? Almost nothing. The transcript is garbled to the point of being incoherent. Phrases like "I think it's a very easier to be found in the city" and "I hope this is not a big thing" suggest either severe audio transcription failure or a clip that was never about testosterone at all.

The video is captioned as a comparison between testosterone gel and injections, tagged with #trt and #testosterona, and appears to be a clip from a podcast featuring someone named Jordi Wild. But based on the transcript provided, no actual medical claims about delivery methods, absorption rates, dosing schedules, or clinical outcomes are present. We cannot fact-check words that were never coherently spoken, at least not as captured here.

That said, the topic the video promises to cover, gel versus injectable testosterone for TRT, is worth examining on its own merits, because this comparison circulates constantly on social media and gets things wrong just as constantly.

Does the science back up the implied comparison?

The gel-versus-injection debate has real clinical data behind it, and the answer is more nuanced than most TikTok takes suggest. Neither delivery method is universally superior. The choice depends on patient-specific factors including compliance, skin sensitivity, hematocrit response, and lifestyle.

Injectable testosterone (cypionate or enanthate) produces well-documented peaks and troughs in serum testosterone levels. A study by Bhasin et al. (2010, New England Journal of Medicine) confirmed that weekly or biweekly injections create supraphysiologic peaks followed by sub-therapeutic troughs in some patients, which can affect mood and energy. Transdermal gels, by contrast, produce more stable daily serum levels but require consistent application and carry a documented transfer risk to partners and children. The FDA has issued warnings about this. A 2011 review by Swerdloff and Wang in the journal Drugs noted that gel adherence issues remain a significant real-world limitation despite better pharmacokinetic profiles in controlled studies.

Neither format has been shown to be superior for long-term cardiovascular or sexual function outcomes in head-to-head trials with sufficient follow-up.

What did they get wrong, or right?

Because the transcript is incoherent, we cannot credit or penalize the creator for specific medical claims. What we can say is that the framing of the video, a clean "comparison" between two TRT methods, is a format that routinely oversimplifies a clinical decision that should involve lab work and physician input.

What frequently goes wrong in this genre of content: creators imply that one method is objectively better, ignore that testosterone delivery choice is individualized, skip the transfer risk conversation for gels entirely, and treat injection frequency as a preference question rather than a pharmacological one. If this video did any of those things, the transcript did not capture it clearly enough to evaluate.

What goes right in this genre, occasionally: acknowledging that gels and injections produce different hormonal stability profiles. That part is true and worth knowing.

What should you actually know?

If you are considering TRT and are trying to decide between gels and injections, here is what the clinical literature actually supports.

• Injections (cypionate, enanthate) typically require administration every one to two weeks, though some clinicians use more frequent smaller doses to reduce peaks and troughs. Frequency matters pharmacologically, not just for convenience.
• Transdermal gels produce more stable serum testosterone but require strict application protocols. The FDA mandated label updates in 2009 warning about secondary exposure risks to women and children from skin contact.
• Neither method has demonstrated clear superiority for libido, bone density, or mood outcomes in large randomized controlled trials. Morgentaler et al. (2015, Mayo Clinic Proceedings) summarized that individualization remains the standard of care.
• Hematocrit elevation, a known TRT side effect, has been observed across both delivery methods and requires monitoring regardless of format.
• Cost, insurance coverage, and patient preference for needle use are legitimate factors in the clinical decision, not just biology.

Do not choose a TRT delivery method based on a TikTok comparison video, including this one. Talk to a clinician who can review your labs.